Related Experiment Video
Updated: May 17, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Non-small cell lung cancer
David S Ettinger1, Wallace Akerley, Hossein Borghaei
1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Journal of the National Comprehensive Cancer Network : JNCCN
|October 12, 2012
Summary
Most non-small cell lung cancer (NSCLC) patients are diagnosed with advanced disease. Identifying stage IV NSCLC early prevents futile treatments and guides systemic therapy, clinical trials, or palliative care decisions.
Area of Science:
- Oncology
- Pulmonology
- Medical Guidelines
Background:
- Non-small cell lung cancer (NSCLC) frequently presents at advanced stages.
- Stage IV NSCLC necessitates systemic therapy, clinical trials, or palliative care.
Purpose of the Study:
- To outline management strategies for stage IV non-small cell lung cancer.
- To emphasize the importance of identifying metastatic disease before aggressive treatment.
Main Methods:
- Guidelines focus on stage IV NSCLC management.
- Recommendations are based on multidisciplinary discussion.
Main Results:
- Early identification of metastatic disease prevents unnecessary and futile treatments.
- Discovery of metastatic disease during surgery may lead to surgical abortion.
Conclusions:
- Treatment decisions for stage IV NSCLC require careful consideration of metastatic status.
- Multidisciplinary discussion is crucial for optimal patient care in advanced NSCLC.